Nursing Elites

1. A client with diabetes mellitus reports tingling in their feet. What is the nurse's best intervention?

• A. Advise the client to avoid wearing tight shoes.
• B. Refer the client to a podiatrist for foot care.
• C. Teach the client about blood sugar control and foot care.
• D. Administer insulin as prescribed.

Correct answer: C

Rationale: The correct intervention for a client with diabetes mellitus experiencing tingling in their feet is to teach the client about blood sugar control and foot care. This is essential because tingling in the feet can be a sign of neuropathy, a common complication of diabetes. Educating the client on maintaining proper blood sugar levels and foot care practices can help manage neuropathy symptoms and prevent complications like ulcers or infections. Advising the client to avoid tight shoes (Choice A) may help with comfort but does not address the underlying issue. Referring the client to a podiatrist (Choice B) is important for foot care but does not directly address blood sugar control. Administering insulin (Choice D) is not the priority for managing tingling in the feet related to neuropathy.

2. A client is admitted with diabetic ketoacidosis (DKA). Which laboratory result would the nurse expect to find in this client?

• A. pH level of 7.45
• B. Serum calcium of 15 mg/dL
• C. Blood glucose of 450 mg/dL
• D. Sodium level of 120 mEq/L

Correct answer: C

Rationale: Clients with diabetic ketoacidosis typically present with elevated blood glucose levels, often above 300 mg/dL. This high blood glucose level, along with other symptoms, helps confirm the diagnosis of DKA. A pH level of 7.45 would be indicative of alkalosis, not the acidosis seen in DKA. A serum calcium level of 15 mg/dL is significantly elevated and is not a typical finding in DKA. A sodium level of 120 mEq/L indicates hyponatremia, which is not a characteristic laboratory finding in DKA.

3. When speaking with a group of teens about chemotherapy side effects for cancer, which side effect would the nurse expect this group to be more interested in discussing?

• A. Mouth sores
• B. Fatigue
• C. Diarrhea
• D. Hair loss

Correct answer: D

Rationale: Teens are more likely to be concerned with hair loss when discussing chemotherapy side effects because it is a visible and emotionally impactful side effect for them. While all the listed side effects are important to consider, hair loss can have a significant impact on a teenager's self-image and emotional well-being, making it a key point of interest for this age group. Mouth sores, fatigue, and diarrhea are also common side effects of chemotherapy, but they may not carry the same level of emotional weight and visibility as hair loss for teens.

4. A client with diabetes insipidus is admitted due to a pituitary tumor. What complication should the nurse monitor closely?

• A. Monitor for elevated blood pressure.
• B. Monitor for ketonuria.
• C. Monitor for peripheral edema.
• D. Monitor for hypokalemia.

Correct answer: D

Rationale: The correct answer is to monitor for hypokalemia. In diabetes insipidus, excessive urination can lead to electrolyte imbalances, particularly low potassium levels (hypokalemia). The loss of potassium through increased urination can result in muscle weakness, cardiac dysrhythmias, and other serious complications. Elevated blood pressure (Choice A) is not a typical complication of diabetes insipidus due to pituitary tumors. Ketonuria (Choice B) is more commonly associated with diabetes mellitus due to inadequate insulin levels. Peripheral edema (Choice C) is not a direct complication of diabetes insipidus.

5. A client is newly prescribed lithium for bipolar disorder. Which finding is most important to report to the healthcare provider?

• A. A serum lithium level of 1.2 mEq/L.
• B. Fine hand tremors noted after starting the medication.
• C. A blood pressure of 110/60 mmHg.
• D. A serum sodium level of 140 mEq/L.

Correct answer: B

Rationale: The correct answer is B. Fine hand tremors noted after starting lithium are an early sign of lithium toxicity. It is crucial to report this finding to the healthcare provider promptly. Adjusting the dose or monitoring serum levels more closely may be necessary to prevent further toxicity. Choice A, a serum lithium level of 1.2 mEq/L, is within the therapeutic range (0.6-1.2 mEq/L) for treating bipolar disorder. Choice C, a blood pressure of 110/60 mmHg, and Choice D, a serum sodium level of 140 mEq/L, are within normal limits and not directly related to lithium therapy or toxicity.

Similar Questions